“Blood Tumor Mutational Burden as a Predictive Biomarker in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)”, Pjmcr, vol. 5, no. 2, pp. 2361–2369, May 2026, doi: 10.66021/pakmcr1041.